Provided by Tiger Fintech (Singapore) Pte. Ltd.

IGM Biosciences

1.43
+0.145011.33%
Volume:200.24K
Turnover:279.90K
Market Cap:85.18M
PE:-0.44
High:1.46
Open:1.27
Low:1.23
Close:1.28
Loading ...

IGM Biosciences (IGMS) was downgraded to a Sell Rating at Morgan Stanley

TIPRANKS
·
10 Jan

IGM Biosciences downgraded to Market Perform from Outperform at BMO Capital

TIPRANKS
·
10 Jan

IGM Biosciences to cut 73% of workforce as latest pivot fails to pan out

Dow Jones
·
10 Jan

IGM Biosciences to Slash Workforce by 73%, Halt Two Drug Programs, Evaluate Alternatives

MT Newswires Live
·
10 Jan

IGM Biosciences to Halt Development of Imvotamab, Cut 73% of Staff

Dow Jones
·
10 Jan

IGM Biosciences halting further development of imvotamab and IGM-2644

TIPRANKS
·
10 Jan

BRIEF-IGM Biosciences Reduces Its Workforce By 73%

Reuters
·
10 Jan

IGM Biosciences Inc -Company Halting Further Development of Imvotamab (Cd20 X Cd3) and IGM-2644 (Cd38 X Cd3)

THOMSON REUTERS
·
10 Jan

IGM Biosciences Inc - Currently Evaluating Internal Options as Well as Potential Strategic Alternatives

THOMSON REUTERS
·
10 Jan

IGM Biosciences Provides Strategic Update on Autoimmunity Pipeline Programs

THOMSON REUTERS
·
10 Jan

IGM Biosciences Inc -Company Reducing Its Workforce by 73%

THOMSON REUTERS
·
10 Jan

IGM Biosciences Provides Strategic Update on Autoimmunity Pipeline Programs

GlobeNewswire
·
10 Jan

BMO Capital Initiates IGM Biosciences at Outperform With $21 Price Target

MT Newswires Live
·
06 Dec 2024

IGM Biosciences Inc : Bmo Initiates Coverage With Outperform Rating; Price Target $21

THOMSON REUTERS
·
06 Dec 2024

IGM Biosciences Initiated at Outperform by BMO Capital

Dow Jones
·
06 Dec 2024

IGM Biosciences initiated with an Outperform at BMO Capital

TIPRANKS
·
06 Dec 2024

IGM Biosciences Insiders Who Sold Avert US$165m Market Cap Dip

Simply Wall St.
·
12 Nov 2024

Stock Track | IGM Biosciences Soars After Bullish Analyst Actions

Stock Track
·
11 Nov 2024

IGM Biosciences price target raised to $27 from $25 at Stifel

TIPRANKS
·
11 Nov 2024

RBC Capital Reaffirms Their Buy Rating on IGM Biosciences (IGMS)

TIPRANKS
·
11 Nov 2024